ReviewJournal of the advanced practitioner in oncology2024

Safety in Subsequent Lines of Therapy in Patients With Relapsed/Refractory Follicular Lymphoma.

Tajuana Bradley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.